Cosmos Health Q2 FY26 net loss widens 115.2% to $6.09 million; revenue rises 28.8% to $18.99 million
COSM•Second-quarter results
Cosmos Health posted Q2 revenue of USD 18.99 million, up 28.8% year over year, while net loss widened to USD 6.09 million.
Gross profit rose to USD 1.51 million; gross margin edged up 0.1 percentage point to 8%.
Six-month performance and cash position
Six-month revenue climbed 29.7% to USD 36.91 million, while net loss widened to USD 8.89 million.
Six-month gross profit fell 10% to USD 2.89 million due to a USD 802,528 Medihelm revenue reversal.
Cash and restricted cash totaled USD 2.45 million at June 30, down from USD 3.46 million at Dec. 31.
